Venture Connectors

Feb. 6: The Apellis Success Story

Join Venture Connectors on Wednesday, Feb. 6, to hear the inspiring success story of Crestwood, Ky.-based Apellis Pharmaceuticals Inc. from President and CEO Cedric Francois, MD, PhD. He will share his experiences with taking the pharmaceutical company public, as well as finding/attracting talent and securing funding. Dr. Francois will also share his perspective on changes in the local entrepreneurial climate during the past decade. Click here to register.

Apellis is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds for the treatment of a broad range of life-threatening or debilitating autoimmune diseases. Dr. Francois co-founded the company in September 2009, and it now has clinical and manufacturing operations all over the world. He also co-founded Potentia Pharmaceuticals Inc., a private biotechnology company that operates as a subsidiary of Apellis, and has served as its President and CEO since 2001.

Dr. Francois earned his medical degree from the University of Leuven in Belgium and his PhD in physiology from the University of Louisville. Following postgraduate training in pediatric and transplant surgery, Dr. Francois served on the research team that performed the first successful hand transplant, of the Louisville Face Transplant Team, whose work supported hand transplantation in Lyon, France in 2005.

Venture Connectors' luncheons are held on the first Wednesday of the month. RSVPs are required for both members and guests. NEW TIME: Doors open at 11:45 a.m., and the meeting runs from noon-1 p.m. NETWORKING WILL TAKE PLACE AFTER THE LUNCH. The lunch is free to members and $40 for nonmembers. Click here to register. We hope to see you Feb. 6!